http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6a426724f962e72fe20749bdb815c69e
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Salomoni |
| name | Paolo Salomoni |
| given-name | Paolo |
| organization-name | University College London, UCL Cancer Institute, London, United Kingdom From the *Department of Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107; the ‡Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104; and the §Department of Hematopoietic Factors, Institute of Medical Science, University of Tokyo, Tokyo 108, Japan Department of Human Genetics and Molecular Biology Program, Memorial Sloan-Kettering Cancer Center, Cornell University, New York, New York 10021 Medical Research Council Toxicology Unit, Leicester LE1 9HN, United Kingdom Samantha Dickson Brain Cancer Unit, University College London Cancer Institute, London WC1E 6BT, UK German Center for Neurodegenerative Diseases (DZNE) Bonn Germany Toxicology Unit, Medical Research Council, University of Leicester, Leicester LE1 9HN, United Kingdom; UCL Cancer Institute, Department of Cancer Biology, London, UK; Nuclear Function Group, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany From the Department of Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson University; the University of Pennsylvania Medical Center, Department of Pathology and Laboratory Medicine, Philadelphia, PA; and the Department of Biomedical Sciences, University of Modena, Italy. Nuclear Function Group, German Centre for Neurodegenerative Diseases (DZNE), Bonn, Germany Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107 Nuclear Function in CNS Pathophysiology, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany 1MRC Toxicology Unit, University of Leicester, Leicester LE1 9HN, England, UK MRC Toxicology Unit, Leicester, UK. ps90@leicester.ac.uk Laboratory of Genetic Instability II, MRC Toxicology Unit, University of Leicester, Leicester, UK From the Department of Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, and the Department of Biomedical Sciences, Section of General Pathology, University of Modena, Modena, Italy. Medical Research Council Toxicology Unit, University of Leicester, Leicester, United Kingdom Nuclear Function Group, German Center for Neurodegenerative Diseases, 53127 Bonn, Germany; 1Samantha Dickson Brain Cancer Unit, University College London Cancer Institute, University College London, London, United Kingdom. German Center for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany From the Cancer Biology and Genetics Program, Department of Pathology, Sloan-Kettering Institute, Weill Graduate School of Medical Sciences, Cornell University, New York, NY. avk UCL Cancer Institute, Samantha Dickson Brain Cancer Unit , London , UK. Samantha Dickson Brain Cancer Unit UCL Cancer Institute London UK From the *Department of Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107; the ‡Department of Biomedical Sciences, University of Modena, 41100 Modena, Italy; and the §Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19102; From the *Department of Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107; the ‡Department of Biomedical Sciences, University of Modena, 41100 Modena, Italy; and the §Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19102 Samantha Dickson Brain Cancer Unit, University College London Cancer Institute, London WC1E 6BT, United Kingdom; *Medical Research Council, Toxicology Unit, Leicester University, Leicester LE1 9HN, United Kingdom; Department of Microbiology and Immunology and Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107-6799; and Department of Biomedical Sciences, Modena University School of Medicine, 41100 Modena, Italy From the Kimmel Cancer Institute, Jefferson Medical College, Philadelphia, PA; and the Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA. UCL Cancer Institute, London, United Kingdom; and aFrom the Department of Human Genetics and the Molecular Biology Program, Memorial Sloan-Kettering Cancer Center, Sloan-Kettering Division, Graduate School of Medical Sciences, Cornell University, New York, New York 10021 Samantha Dickson Brain Cancer Unit, UCL Cancer Institute, Paul O'Gorman Building, London, UK MRC Toxicology Unit, Lancaster Road, P.O. Box 138, Leicester LE1 9HN, United Kingdom Kimmel Cancer Institute, Jefferson Medical College, Blumle Life Science Building 630, 233 South 10th Street, Philadelphia, PA 19107; and Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, 19104 1Molecular Biology Program; 2Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021 Department of Microbiology/Immunology, Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107 |
Incoming Links
Total number of triples: 125.